Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000926617-15-000056
Filing Date
2015-08-13
Accepted
2015-08-13 09:11:21
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q c617-20150630x10q.htm 10-Q 899458
2 EX-31.1 c617-20150630xex311.htm EX-31.1 16749
3 EX-31.2 c617-20150630xex312.htm EX-31.2 16851
4 EX-32.1 c617-20150630xex321.htm EX-32.1 14240
5 GRAPHIC c617-20150630x10qg001.jpg GRAPHIC 6840
  Complete submission text file 0000926617-15-000056.txt   2144933

Data Files

Seq Description Document Type Size
6 EX-101.INS c617-20150630.xml EX-101.INS 205018
7 EX-101.SCH c617-20150630.xsd EX-101.SCH 16844
8 EX-101.CAL c617-20150630_cal.xml EX-101.CAL 26272
9 EX-101.DEF c617-20150630_def.xml EX-101.DEF 42115
10 EX-101.LAB c617-20150630_lab.xml EX-101.LAB 143045
11 EX-101.PRE c617-20150630_pre.xml EX-101.PRE 114980
Mailing Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738
Business Address 12117 BEE CAVES ROAD BUILDING THREE SUITE 100 AUSTIN TX 78738 512-519-0400
VERMILLION, INC. (Filer) CIK: 0000926617 (see all company filings)

EIN.: 330595156 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34810 | Film No.: 151048915
SIC: 2835 In Vitro & In Vivo Diagnostic Substances